Products
Platform
Research
Market
Learn
Compare Tata India Pharma & Healthcare Fund vs SBI Healthcare Opportunities Fund
Fund Comparison
Detailed comparison on parameters like NAV | Returns | Risk | Rating | Analysis
Fund Details
Risk | Very High | Very High |
Rating | 3.0 | 5.0 |
Min SIP Amount | ₹100 | ₹500 |
Expense Ratio | 2.1 | 1.93 |
NAV | ₹31.15 | ₹435.53 |
Fund Started | 04 Dec 2015 | 04 Jun 1999 |
Fund Size | ₹1339.00 Cr | ₹4026.55 Cr |
Exit Load | Exit load of 0.25% if redeemed within 30 days. | Exit load of 0.50% if redeemed within 15 days |
Risk
Very High
Very High
Rating
3.0
5.0
Min SIP Amount
₹100
₹500
Expense Ratio
2.1
1.93
NAV
₹31.15
₹435.53
Fund Started
04 Dec 2015
04 Jun 1999
Fund Size
₹1339.00 Cr
₹4026.55 Cr
Exit Load
Exit load of 0.25% if redeemed within 30 days.
Exit load of 0.50% if redeemed within 15 days
Returns
1 Year | 4.00% | 10.33% |
3 Year | 24.00% | 27.12% |
5 Year | 18.97% | 20.45% |
1 Year
4.00%
10.33%
3 Year
24.00%
27.12%
5 Year
18.97%
20.45%
Holding Analysis
Equity | 93.81% | 97.60% |
Cash | 6.19% | 2.33% |
Equity
93.81%
97.60%
Cash
6.19%
2.33%
Top Holdings
Top 10 Holdings |
|
|
Top 10 Holdings
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 10.92% |
Cipla Ltd. | 6.62% |
Apollo Hospitals Enterprise Ltd. | 5.20% |
Lupin Ltd. | 4.77% |
Healthcare Global Enterprises Ltd. | 4.38% |
Torrent Pharmaceuticals Ltd. | 4.32% |
Aster DM Healthcare Ltd. | 4.32% |
Fortis Healthcare Ltd. | 4.00% |
Alkem Laboratories Ltd. | 4.00% |
Max Healthcare Institute Ltd. | 3.80% |
Name | Assets |
|---|---|
Sun Pharmaceutical Industries Ltd. | 11.44% |
Divi's Laboratories Ltd. | 7.21% |
Max Healthcare Institute Ltd. | 6.50% |
Cipla Ltd. | 4.63% |
Lonza Group Ag | 4.09% |
Lupin Ltd. | 4.02% |
Gland Pharma Ltd. | 3.59% |
Mankind Pharma Ltd. | 3.57% |
Acutaas Chemicals Ltd. | 3.30% |
Krishna Institute of Medical Sciences Ltd | 3.26% |
Fund Manager
Name | Meeta Shetty | Tanmaya Desai |
Start Date | 09 Nov 2018 | 27 Jun 2011 |
Name
Meeta Shetty
Tanmaya Desai
Start Date
09 Nov 2018
27 Jun 2011
About Fund
Description | The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India. | The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space. |
Launch Date | 04 Dec 2015 | 04 Jun 1999 |
Description
The scheme seeks long term capital appreciation by investing atleast 80% of it's net assets in equity/equity related instruments of the companies in the pharma & healthcare sectors in India.
The scheme seeks to provide the investors with the opportunity of long-term capital appreciation by investing in a diversified portfolio of equity and equity related securities in Healthcare space.
Launch Date
04 Dec 2015
04 Jun 1999
